ABSTRACT

Recent evidence shows that commonly prescribed drugs, such as non-steroidal anti-inflammatory drugs (NSAIDs), metformin, and statins, may have beneficial roles in the primary chemoprevention of breast cancer. Therefore, these drugs could potentially be used in addition to the hormonal drugs currently used for this purpose (namely, selective estrogen receptor modulators and aromatase inhibitors) due to their alternative mechanisms of action.

Keywords: Chemoprophylaxis, breast neoplasms, hydroxymethylglutaryl-CoA reductase inhibitors, metformin, anti-inflammatory agents, non-steroidal